What Should You Know
If you’re not sure what to do in the current market situation, you’re not alone. Investors around the world have been battered recently, as the crisis in the U.S. housing market took on broader implications. On September 29, following defeat of the bailout legislation by Congress, the Dow Jones Industrial Average posted a record 778-point loss, making a cumulative 27% decline since reaching its highest all time closing on October 9, 2007. Over that same period, the Standard & Poor’s 500 was down 29.8%, and the Nasdaq Composite shed 30.7%. Even when the emergency Economic Stabilization Act was later passed on October 3, the markets were down sharply, on fears that this bill wouldn’t avert a severe recession. The questions on everyone’s minds are: Just how bad are the markets and the economy going to get? What should we do about it? Is it time to sell every stock we own, withdraw all of our money from banks, and bury everything in the backyard? Or are we really looking at an opportunity to purchase stocks at low prices?
The truth of the matter is that no one, anywhere, knows for certain where the economy or stock market is headed. But emotion is often an investor’s worst enemy, both on the way up and on the way down. The last stages of a bull market are often led by investors desperate to join the crowd and make fast money, often entering the market just as it is peaking. Conversely, the last stages of a bear market are often marked by losses as investors finally give up, selling stocks for fear of future declines. The way to overcome these emotions is to think calmly and rationally, refresh your perspective on the long-term and recent history of the market, review your investment strategy, and methodically analyze your current portfolio. Only after you’ve taken these steps should you consider any changes to your investments.
Host Brian Kohute from HJ Wealth Management and Jane Scaccetti, CEO from Drucker & Scaccetti have put together a Special Show to help you reduce your 2014 Tax Liability. Get valuable tips on how you can stay on top of the … Read More!
Kimon C. Hatza, Partner Millcrest Law, LLP Charles Huntington, Pennsylvania Bio PR Chair Alessandro Fatatis, MD, Ph. D. Founder Kerberos Biopharmaceuticals, Inc. The focus of Dr. Fatatis’s research is the identification of novel biomarkers and therapeutic targets for the management … Read More!
Charlie Shields, Wells Fargo Advisors Patricia Dunn, Merrill Lynch Tom Giacoponello, CEO of Baby Life Seat, Inc. The Baby Life Seat is a game-changer in the infant car seat industry. The prototype has been developed and tested by the US … Read More!
Brian Kohute – HJ Wealth Management Patricia Tawadros – Xercel Carol Kivler – Kivler Communications Carol A. Kivler, MS, CSP, President of Kivler Communications, First diagnosed with a mental illness in 1990, Carol was challenged with periodic acute bouts of … Read More!
Host: Richard Whitfield VCWorld.com Co-Host: Pat Welde – Merrill Lynch Guest: Richard Natow, CEO & Robert Cohen, Exec. VP of the Prestige Group Inc. Richard Natow is true to the entrepreneurial spirit! Richard began his business career when, as a young man … Read More!
Jim Butler, CFP, AIF Videre Wealth Management Dave Dewitt, CFP Dewitt Capital Management Ronald Smyser Spinnaker Leadership Associates, Inc. Ron Smyser, Chairman of Spinnaker Leadership Associates, Inc., is a straightforward, no-nonsense leadership and business management advisor. Over the last twenty … Read More!
Charlie Huntington: PA BIO Chair PR Committee Kimon Hatza, Esq.: Millcrest Law, LLP Michael Patterson, CEO Graphene Frontiers About Michael Patterson Entrepreneurial executive making the world a better place with graphene technology. Self-proclaimed polymath and avowed meliorist. About Graphene Frontiers … Read More!
Host: Charlie Shields – Wells Fargo Advisors LLC Co Host: David Emery – Marshall Financial Group Inc. Guest: Joseph Murin – Mortgage Expert About Joe Murin Mr. Joseph J. Murin, also known as Joe, Co-founded The Collingwood Group, LLC in … Read More!
Karen is currently Managing Partner of DreamIt Ventures in charge of DreamIt Funds. DreamIt Ventures is a top startup accelerator which brings in promising early-stage companies for a 3 to 4 month program where we focus on validating and de-risking … Read More!
Anthony V. Coletta, M.D., M.B.A, is the president and chief executive officer of Tandigm Health, a groundbreaking joint venture by Independence Blue Cross (IBC) and Health Care Partners, LLC that will work in tandem with primary care physicians to create … Read More!